SEC Filing Details
Document Details
Form
Filing Date
March 11, 2020
Document Date
March 11, 2020
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Enliven Therapeutics
Issuer
ENLIVEN THERAPEUTICS, INC.
Filer
Chin Mark